Comparative Analysis of HbA1c Estimation Using Immunoturbidimetry and High-Pressure Liquid Chromatography Methods in

Chanchal Dhingra1, Namrata Rao1, Shefali Singh1

  • 1Department of Biochemistry, Dr Ram Manohar Institute of Medical Sciences, Lucknow, Uttar Pradesh.

EJIFCC
|November 7, 2024
PubMed

Insights

High-pressure liquid chromatography (HPLC) accurately measures HbA1c in chronic kidney disease (CKD) patients, unlike turbidimetric inhibition immunoassay (TINIA), which fails in anemic individuals. HPLC is recommended for reliable diabetes mellitus monitoring in CKD.

Area of Science:

  • Clinical Chemistry
  • Nephrology
  • Endocrinology

Background:

  • Chronic kidney disease (CKD) poses challenges in monitoring glycemic control, particularly in patients with diabetes mellitus (DM).
  • Anemia and uremia in CKD patients complicate accurate measurement of Hemoglobin A1c (HbA1c).

Purpose of the Study:

  • To compare the performance of turbidimetric inhibition immunoassay (TINIA) and high-pressure liquid chromatography (HPLC) for HbA1c measurement in non-dialysis CKD patients.
  • To identify factors affecting HbA1c measurement accuracy in this population.

Main Methods:

  • An analytical cross-sectional study was conducted with 127 non-dialysis CKD patients.
  • HbA1c levels were measured using both TINIA and HPLC methods.
  • Correlation and agreement between the two methods were analyzed, along with the influence of anemia and carbamylated hemoglobin (CHb).

Main Results:

  • TINIA failed to detect HbA1c in 27% of anemic patients, while HPLC provided measurable results for all.
  • A strong positive correlation (R2=0.861) and substantial agreement (Cohen's kappa 0.657) were observed between TINIA and HPLC in the 100 patients where both methods yielded results.
  • HPLC reported significantly higher HbA1c levels in diabetic CKD patients compared to TINIA. Carbamylated hemoglobin (CHb) correlated with both HbA1c measurements and serum urea levels.

Conclusions:

  • HPLC is superior to TINIA for HbA1c measurement in CKD patients, especially those with anemia, as it provides complete assessment.
  • TINIA underestimates HbA1c in diabetic CKD patients due to interference from factors like low hemoglobin and high carbamylated hemoglobin.
  • Accurate HbA1c monitoring in CKD requires methods robust to anemia and other biochemical alterations.
Abstract

Related Concept Videos

Renal Drug Clearance: Comparison Between Renal Excretion Methods01:08

Renal Drug Clearance: Comparison Between Renal Excretion Methods

Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...